Mortality and Causes of Death among Individuals in a National Opioid Agonist Treatment Cohort

Schwarz, Tanja; Anzenberger, Judith; Busch, Martin; Schernhammer, Eva S.; Strohmaier, Susanne (2026): Mortality and Causes of Death among Individuals in a National Opioid Agonist Treatment Cohort. European Addiction Research. ISSN 1022-6877

Full text not available from this repository.
Official URL (please open in a new browser tab/window): https://doi.org/10.1159/ear/acrag005

Abstract

Introduction: People with opioid use disorder experience markedly elevated all-cause and cause-specific mortality. Opioid-agonist treatment (OAT) reduces mortality risk, and OAT populations across Europe are ageing, with cardiovascular, respiratory, and liver diseases accounting for a growing proportion of deaths. However, cause-specific mortality beyond overdose remains poorly characterized in large national cohorts. Methods: We conducted a retrospective cohort study including all 26,031 individuals (76% men) recorded in the Austrian national OAT registry between January 1, 2002, and December 31, 2019, linked to the national causes of death registry with follow-up through December 31, 2021. We calculated sex-specific age-standardized mortality rates per 100,000 person-years (2013 European Standard Population), standardized rate ratios (SRRs), and cause-specific standardized mortality ratios (SMRs) compared with the Austrian general population. Results: Across 278,959 person-years of follow-up, 2,358 deaths occurred. Cohort members had substantially higher mortality across all causes, with greater excess among women (SRR 7.06, 95% CI 6.45-7.72) than men (3.86; 3.69-4.04). Beyond substance use-related causes (SMR 33.2, 95% CI 31.4-35.2), the highest SMRs were found for viral hepatitis (63.8, 52.3-77.8), HIV (48.6, 39.0-60.6), and valvular heart diseases and endocarditis (28.4, 18.6-43.6). By the early to mid-40s, deaths from non-communicable diseases collectively exceeded those from substance use-related causes. Conclusion: Austria´s national OAT cohort experiences substantial excess mortality across all major causes, with high relative excess for substance use-related, infectious, and liver-related conditions. As OAT populations age, non-communicable diseases account for an increasing share of deaths. Future analyses linking the cohort to additional data sources will be needed to disentangle the underlying contributions to this excess mortality.

Item Type: Article
Uncontrolled Keywords: Opioid-agonist treatment, Opioid use disorder, Mortality, Causes of death, Austria
Subjects: Kompetenzzentrum Sucht
Date Deposited: 02 Nov 2026 09:54
Last Modified: 02 Nov 2026 09:54
URI: https://jasmin.goeg.at/id/eprint/5784